(Q59317616)

English

Cost-effectiveness of HER2 testing and 1-year adjuvant trastuzumab therapy for early breast cancer

scientific article published on 06 December 2007

Statements

Cost-effectiveness of HER2 testing and 1-year adjuvant trastuzumab therapy for early breast cancer (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit